Top 10 pharmaceutical companies by revenues in 2026 | Official Figures | iPharmaCenter Badari Andukuri 6 days ago 5 min read Updated: 1 day ago The first quarter of 2026 confirmed that GLP-1 drugs are still rewriting the global pharmaceutical revenue rankings
As of February 21, 2025, physicians (503A facilities) and state-licensed pharmacies and are permitted to compound semaglutide until April 22, 2025, while outsourcing facilities (503B) may continue until May 22, 2025, or until a court decision is issued in the OFA v
Mean weight loss ranged from 9.1% at 2.5 mg to 14.7% at 15 mg, versus 1.7% on placebo, with no evidence of plateauing by the end of treatment (Figure 1)
Formato stick, fcil de llevar
GLP-1 plays several critical roles in glucose and appetite regulation: it stimulates insulin release from the pancreas, inhibits glucagon secretion to prevent excess glucose production, slows gastric emptying to moderate post-meal blood sugar spikes, and promotes satiety by acting on hunger centers in the brain (6)(23)